• Home Nonprofit product advancement partnerships.

Nonprofit product advancement partnerships.

As mentioned today in a symposium at the 58th annual meeting of the American Culture of Tropical Medicine and Hygiene , these collaborations are checking new avenues of usage of industry technology, knowledge, and capabilities, allowing the harnessing of industry resources for new item innovation. The necessity for these collaborations between market and global health nonprofits results from the lack of effective prevention or treatments for many infectious diseases of the developing globe. There is a tremendous need for fresh R&D that could lead to new treatments.

Myla Goldman, of the University of Virginia in Charlottesville, and Dr. Olaf Stuve, of the University of Texas Southwestern INFIRMARY at Dallas, wrote in an accompanying editorial. Most importantly, it offers the first evidence, to your knowledge, that quitting cigarette smoking seems to delay onset of secondary progressive MS and provide protective benefit. Therefore, even after MS diagnosis, smoking can be a risk factor worthy of modifying, Goldman and Stuve wrote..Myla Goldman, of the University of Virginia in Charlottesville, and Dr. Olaf Stuve, of the University of Texas Southwestern INFIRMARY at Dallas, wrote in an accompanying editorial. Most importantly, it offers the first evidence, to your knowledge, that quitting cigarette smoking seems to delay onset of secondary progressive MS and provide protective benefit. Therefore, even after MS diagnosis, smoking can be a risk factor worthy of modifying, Goldman and Stuve wrote..